As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.
28 Analysts have issued a Hansoh Pharmaceutical Group Company forecast:
28 Analysts have issued a Hansoh Pharmaceutical Group Company forecast:
Jun '25 |
+/-
%
|
||
Revenue | 14,421 14,421 |
9%
9%
|
|
Gross Profit | 13,118 13,118 |
9%
9%
|
|
EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | 5,576 5,576 |
21%
21%
|
Net Profit | 5,228 5,228 |
1%
1%
|
In millions HKD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. Its products include oncology, anti-infective, anti-diabetic, gastrointestinal, and cardiovascular drugs. The company was founded by Huijuan Zhong on December 2, 2015 and is headquartered in Lianyungang, China.
Head office | Cayman Islands |
CEO | Hui Zhong |
Employees | 8,989 |
Founded | 2015 |
Website | www.hspharm.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.